Stocktoria
Rafael Holdings, Inc. RFL
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 2018-03-12
Rafael Holdings, Inc. statistics & valuation
Market cap$143.6M
P / B1.5×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -3179.8% | -16111.0% | -5391.8% | -14750.5% | -3516.1% |
| Net margin | -3328.2% | -5401.9% | -672.4% | -30404.4% | -2875.4% |
| FCF margin | -2064.1% | -1247.3% | — | -6361.2% | -1970.9% |
| Return on assets | -26.7% | -35.5% | -1.9% | -105.4% | -15.0% |
| Return on equity | -31.0% | -39.9% | -1.9% | -124.0% | -16.9% |
| Current ratio | 4.89 | 9.65 | 38.67 | 5.15 | 0.85 |
| Revenue growth | 44.0% | 128.3% | -32.0% | -48.9% | -83.7% |
Source: SEC EDGAR filings · CIK 0001713863 · as of 2025-07-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.